Latest Abagovomab Stories
ROCHESTER, N.Y., Dec. 9, 2014 /PRNewswire/ -- Vaccinex, Inc.
Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.
TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc.
New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies”
Reportbuyer.com just published a new market research report:
A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease.
Tokyo, Jan 11, 2013 - (JCN Newswire) - Eisai Co., Ltd.
- totally perplexed and mixed up.